Google+ Facebook Twitter Twitter

Blood test for brain tumours

US researchers are developing the means to detect tumour biomarkers through a simple blood test, avoiding invasive surgery.

A team of engineers, physicians and researchers has developed a groundbreaking, proof-of-concept technique.

It allows biomarkers from a brain tumour to pass through the tough blood-brain barrier into a patient’s blood using non-invasive focused ultrasound and tiny bubbles, potentially eliminating the need for a surgical biopsy.

Researchers had previously learned how to send a drug through the blood-brain barrier into the brain via the bloodstream. But, until now, no one had found a way to release tumour-specific biomarkers – in this case, messenger RNA (mRNA) – from brain to blood.

Hong Chen, a biomedical engineer, said: “Our... technique may make it possible to perform a blood test for brain cancer patients.”

Related Articles

Curing sickle cell disease

Doctors at the University of Illinois Hospital have cured seven adult patients of sickle cell disease.

Blood Bag

Change for blood transfusion inspections

Chris Elliott, Chair of the IBMS Specialist Advisory Panel (Transfusion), discusses changes in the MHRA assessment and inspection regime for hospital blood transfusion laboratories. 

Journal-based learning: iStock

May: Journal-based learning

Each article’s contents should be read, researched and understood, and you should then come to a decision on each question. The pass mark is 17 out of 20 questions answered correctly. JBL exercises may be completed at any time until the published deadline date. Please select your choice of correct answers and complete the exercises online at:

CRP analyser aids early decision making

New research indicates HORIBA Medical UK’s Microsemi point-of-care (POC) CRP analyser enables rapid clinical decision-making, saves time and reduces costs in emergency paediatric units.